GEN1286

· Genmab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GEN1286, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]